Atrial Fibrillation Impairs the Diagnostic Performance of Cardiac Natriuretic Peptides in Dyspneic Patients: Results From the BACH Study (Biomarkers in ACute Heart Failure)
- 30 June 2013
- journal article
- research article
- Published by Elsevier BV in JACC: Heart Failure
- Vol. 1 (3), 192-199
- https://doi.org/10.1016/j.jchf.2013.02.004
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Association of atrial fibrillation and amino-terminal pro–brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) studyAmerican Heart Journal, 2007
- Determinants of Brain Natriuretic Peptide Levels in Patients With Lone Atrial FibrillationCirculation Journal, 2006
- NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patientsEuropean Heart Journal, 2005
- Impact of Atrial Fibrillation on the Diagnostic Performance of B-Type Natriuretic Peptide Concentration in Dyspneic Patients: An Analysis From the Breathing Not Properly Multinational StudyJournal of the American College of Cardiology, 2005
- Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMETEuropean Heart Journal, 2005
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureThe New England Journal of Medicine, 2002
- Prevalence of Diagnosed Atrial Fibrillation in AdultsJAMA, 2001
- EVALUATION AND MANAGEMENT OF ATRIAL FIBRILLATION IN THE EMERGENCY DEPARTMENTEmergency Medicine Clinics of North America, 1998
- The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the manitoba follow-up studyThe American Journal of Medicine, 1995
- Independent Risk Factors for Atrial Fibrillation in a Population-Based CohortJAMA, 1994